Who Is Joseph Kim?
Joseph Kim is a former CEO of Inovio Pharmaceuticals, a biotechnology company focused on vaccines and immune therapies. He led the company through early-stage development of DNA-based vaccine platforms.
Joseph Kim Inovio Net Worth
Public estimates of Joseph Kim's net worth vary based on Inovio stock holdings and reported compensation. As a former executive, his wealth is closely tied to the company's market valuation and equity ownership.
Inovio Pharmaceuticals Background
Inovio Pharmaceuticals develops vaccines using its proprietary DNA medicine technology. The company has worked on infectious disease and oncology programs, with products evaluated in clinical trials.
For current financial details and corporate filings, visit the U.S. Securities and Exchange Commission.
